5.1  0.78 (18.06%)		07-01 16:00
Open: 4.4 High: 5.15 Volume: 313,329		Pre. Close: 4.32 Low: 4.4 Market Cap: 95(M)

Short term
Mid term
Targets	6-month :	6.28	1-year :	7.33
Resists	First :	5.38	Second :	6.28
Pivot price	4.55
Supports	First :	4.52	Second :	4
MAs	MA(5) :	4.58	MA(20) :	4.56
	MA(100) :	4.08	MA(250) :	8.12
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	46.6	D(3) :	39.8
RSI	RSI(14): 59
52-week	High :	21.36	Low :	3

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ OM ] has closed below upper band by 3.1%. Bollinger Bands are 2.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	5.16 - 5.2	5.2 - 5.23
Low:	4.33 - 4.36	4.36 - 4.4
Close:	5.03 - 5.1	5.1 - 5.16

Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.

Mon, 29 Jun 2026
Form 4 Outset Medical Inc For: 29 June By Investing.com - Investing.com Nigeria

Mon, 29 Jun 2026
[Form 4] Outset Medical, Inc. Insider Trading Activity - Stock Titan

Mon, 29 Jun 2026
Outset Medical (OM) CFO receives 71,630 RSUs with 3-year vesting - Stock Titan

Mon, 29 Jun 2026
Outset Medical (OM) CEO Leslie Trigg awarded 99,160 RSUs in new equity grant - Stock Titan

Mon, 29 Jun 2026
Outset Medical, Inc.(NasdaqGS: OM) dropped from Russell 2000 Dynamic Index - marketscreener.com

Mon, 29 Jun 2026
Outset Medical, Inc.(NasdaqGS: OM) dropped from Russell 3000 Value Benchmark - marketscreener.com

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	19 (M)
Shares Float	15 (M)
Held by Insiders	3.8 (%)
Held by Institutions	84.1 (%)
Shares Short	1,970 (K)
Shares Short P.Month	2,050 (K)

EPS	-2.75
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	6.03
Profit Margin	-63.7 %
Operating Margin	-60.8 %
Return on Assets (ttm)	-15.3 %
Return on Equity (ttm)	-53.2 %
Qtrly Rev. Growth	-6.4 %
Gross Profit (p.s.)	2.57
Sales Per Share	6.34
EBITDA (p.s.)	-3.42
Qtrly Earnings Growth	0 %
Operating Cash Flow	-34 (M)
Levered Free Cash Flow	-10 (M)

PE Ratio	-1.87
PEG Ratio	0
Price to Book value	0.84
Price to Sales	0.8
Price to Cash Flow	-2.83

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.